Hormone therapy: Difference between revisions

	WikiDoc Resources for Hormone therapy
Articles
Most recent articles on Hormone therapy Most cited articles on Hormone therapy Review articles on Hormone therapy Articles on Hormone therapy in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Hormone therapy Images of Hormone therapy Photos of Hormone therapy Podcasts & MP3s on Hormone therapy Videos on Hormone therapy
Evidence Based Medicine
Cochrane Collaboration on Hormone therapy Bandolier on Hormone therapy TRIP on Hormone therapy
Clinical Trials
Ongoing Trials on Hormone therapy at Clinical Trials.gov Trial results on Hormone therapy Clinical Trials on Hormone therapy at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Hormone therapy NICE Guidance on Hormone therapy NHS PRODIGY Guidance FDA on Hormone therapy CDC on Hormone therapy
Books
Books on Hormone therapy
News
Hormone therapy in the news Be alerted to news on Hormone therapy News trends on Hormone therapy
Commentary
Blogs on Hormone therapy
Definitions
Definitions of Hormone therapy
Patient Resources / Community
Patient resources on Hormone therapy Discussion groups on Hormone therapy Patient Handouts on Hormone therapy Directions to Hospitals Treating Hormone therapy Risk calculators and risk factors for Hormone therapy
Healthcare Provider Resources
Symptoms of Hormone therapy Causes & Risk Factors for Hormone therapy Diagnostic studies for Hormone therapy Treatment of Hormone therapy
Continuing Medical Education (CME)
CME Programs on Hormone therapy
International
Hormone therapy en Espanol Hormone therapy en Francais
Business
Hormone therapy in the Marketplace Patents on Hormone therapy
Experimental / Informatics
List of terms related to Hormone therapy

VisualWikitext

Latest revision as of 22:07, 4 December 2022

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Hormone therapy, or hormonal therapy is the use of hormones in medical treatment. Treatment with hormone antagonists may also referred to as hormonal therapy. Wikipedia has the following articles regarding this topic:

Cancer

Hormonal therapy (oncology) for treatment of cancer

Aging

Hormone replacement therapy (menopause) following menopause
Testosterone replacement in males with low levels due to disease or aging

Depression

Testosterone therapy^[1], especially among males with low testosterone levels. Testosterone may improve depressive symptoms in hypogonadal, older males^[2].

Sex reassignment

Hormone replacement therapy (female-to-male) in sex reassignment therapy for transmen
Hormone replacement therapy (male-to-female) in sex reassignment therapy for transwomen

Intersex conditions

Hormone therapy in Klinefelter's syndrome
Hormone therapy in Turner syndrome

Hormonal deficiency

Growth hormone replacement as a treatment for growth hormone deficiency
Thyroid hormone replacement in hypothyroidism

Metabolism

Testosterone therapy may^[3] or may not^[4] improve the metabolism of glucose and lipids.

Psychological treatment

Chemical castration of violent sex offenders

Adverse effects of testosterone

Testosterone may in case cardiovascular disease in older males^[5].

The Food and Drug Administration was warned of dangers from testosterone^[6]^[7]

de:Hormontherapie nl:Hormoonbehandeling fi:Hormonihoito

Template:WikiDoc Sources

↑ Walther A, Breidenstein J, Miller R (2019). "Association of Testosterone Treatment With Alleviation of Depressive Symptoms in Men: A Systematic Review and Meta-analysis". JAMA Psychiatry. 76 (1): 31–40. doi:10.1001/jamapsychiatry.2018.2734. PMC 6583468 Check |pmc= value (help). PMID 30427999.
↑ Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA; et al. (2016). "Effects of Testosterone Treatment in Older Men". N Engl J Med. 374 (7): 611–24. doi:10.1056/NEJMoa1506119. PMC 5209754. PMID 26886521. Review in: Ann Intern Med. 2016 May 17;164(10):JC56
↑ Jones TH, Arver S, Behre HM, Buvat J, Meuleman E, Moncada I; et al. (2011). "Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study)". Diabetes Care. 34 (4): 828–37. doi:10.2337/dc10-1233. PMC 3064036. PMID 21386088.
↑ Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, Aleman A, Lock TM, Bosch JL; et al. (2008). "Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial". JAMA. 299 (1): 39–52. doi:10.1001/jama.2007.51. PMID 18167405. Review in: ACP J Club. 2008 May 20;148(3):4 Review in: Evid Based Med. 2008 Jun;13(3):71
↑ Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM; et al. (2010). "Adverse events associated with testosterone administration". N Engl J Med. 363 (2): 109–22. doi:10.1056/NEJMoa1000485. PMC 3440621. PMID 20592293. Review in: Ann Intern Med. 2010 Dec 21;153(12):JC6-7
↑ Food and Drug Administration. DA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use. 02/2018. Available at https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-cautions-about-using-testosterone-products-low-testosterone-due
↑ Food and Drug Administration. FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use. 03/2015. Available at https://wayback.archive-it.org/7993/20161022203711/http://www.fda.gov/Drugs/DrugSafety/ucm436259.htm

[pmid30427999-1] Walther A, Breidenstein J, Miller R (2019). "Association of Testosterone Treatment With Alleviation of Depressive Symptoms in Men: A Systematic Review and Meta-analysis". JAMA Psychiatry. 76 (1): 31–40. doi:10.1001/jamapsychiatry.2018.2734. PMC 6583468 Check |pmc= value (help). PMID 30427999.

[pmid26886521-2] Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA; et al. (2016). "Effects of Testosterone Treatment in Older Men". N Engl J Med. 374 (7): 611–24. doi:10.1056/NEJMoa1506119. PMC 5209754. PMID 26886521. Review in: Ann Intern Med. 2016 May 17;164(10):JC56

[pmid21386088-3] Jones TH, Arver S, Behre HM, Buvat J, Meuleman E, Moncada I; et al. (2011). "Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study)". Diabetes Care. 34 (4): 828–37. doi:10.2337/dc10-1233. PMC 3064036. PMID 21386088.

[pmid18167405-4] Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, Aleman A, Lock TM, Bosch JL; et al. (2008). "Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial". JAMA. 299 (1): 39–52. doi:10.1001/jama.2007.51. PMID 18167405. Review in: ACP J Club. 2008 May 20;148(3):4 Review in: Evid Based Med. 2008 Jun;13(3):71

[pmid20592293-5] Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM; et al. (2010). "Adverse events associated with testosterone administration". N Engl J Med. 363 (2): 109–22. doi:10.1056/NEJMoa1000485. PMC 3440621. PMID 20592293. Review in: Ann Intern Med. 2010 Dec 21;153(12):JC6-7

[6] Food and Drug Administration. DA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use. 02/2018. Available at https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-cautions-about-using-testosterone-products-low-testosterone-due

[7] Food and Drug Administration. FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use. 03/2015. Available at https://wayback.archive-it.org/7993/20161022203711/http://www.fda.gov/Drugs/DrugSafety/ucm436259.htm

[1]

[2]

[3]

[4]

[5]

[6]

[7]

@@ Line 34: / Line 34: @@
 * Chemical castration of violent sex offenders
-==Adverse effects of testosterone--
+==Adverse effects of testosterone==
 Testosterone may in case cardiovascular disease in older males<ref name="pmid20592293">{{cite journal| author=Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM | display-authors=etal| title=Adverse events associated with testosterone administration. | journal=N Engl J Med | year= 2010 | volume= 363 | issue= 2 | pages= 109-22 | pmid=20592293 | doi=10.1056/NEJMoa1000485 | pmc=3440621 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20592293  }}  [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=&cmd=prlinks&id=21173408 Review in: Ann Intern Med. 2010 Dec 21;153(12):JC6-7] </ref>.
+The [[Food and Drug Administration]] was warned of dangers from testosterone<ref>Food and Drug Administration. DA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use. 02/2018. Available at https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-cautions-about-using-testosterone-products-low-testosterone-due</ref><ref>Food and Drug Administration. FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use. 03/2015. Available at https://wayback.archive-it.org/7993/20161022203711/http://www.fda.gov/Drugs/DrugSafety/ucm436259.htm</ref>
 <br>